Editor’s highlights from the Journal of Comparative Effectiveness Research – March 2021

Written by Laura Dormer, Editor
Comparative effectiveness research Health economics Health technology assessment Journal articles Oncology and hematology

In this latest instalment of her regular column, Laura Dormer, Editorial Director at Future Science Group (London, UK), shares some of her highlights from the latest issues of our sister journal, the Journal of Comparative Effectiveness Research. I’m pleased to bring you my highlights from the March issue of the Journal of Comparative Effectiveness Research, which this month includes articles on assessing the value of potential cures; comparing first-line treatments for metastatic melanoma; and estimating the value of life lost to COVID-19 at the state level in the USA. As always, these papers are available for members of The Evidence...

To view this content, please register now for access

It's completely free